{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:13:47Z","timestamp":1790010827899,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interleukin-38 has recently been shown to have anti-inflammatory properties in lung inflammatory diseases. However, the effects of IL-38 in viral pneumonia remains unknown. In the present study, we demonstrate that circulating IL-38 concentrations together with IL-36\u03b1 increased significantly in influenza and COVID-19 patients, and the level of IL-38 and IL-36\u03b1 correlated negatively and positively with disease severity and inflammation, respectively. In the co-cultured human respiratory epithelial cells with macrophages to mimic lung microenvironment in vitro, IL-38 was able to alleviate inflammatory responses by inhibiting poly(I:C)-induced overproduction of pro-inflammatory cytokines and chemokines through intracellular STAT1, STAT3, p38 MAPK, ERK1\/2, MEK, and NF-\u03baB signaling pathways. Intriguingly, transcriptomic profiling revealed that IL-38 targeted genes were associated with the host innate immune response to virus. We also found that IL-38 counteracts the biological processes induced by IL-36\u03b1 in the co-culture. Furthermore, the administration of recombinant IL-38 could mitigate poly I:C-induced lung injury, with reduced early accumulation of neutrophils and macrophages in bronchoalveolar lavage fluid, activation of lymphocytes, production of pro-inflammatory cytokines and chemokines and permeability of the alveolar-epithelial barrier. Taken together, our study indicates that IL-38 plays a crucial role in protection from exaggerated pulmonary inflammation during poly(I:C)-induced pneumonia, thereby providing the basis of a novel therapeutic target for respiratory viral infections.<\/jats:p>","DOI":"10.1038\/s41419-020-03283-2","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T20:09:55Z","timestamp":1610050195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections"],"prefix":"10.1038","volume":"12","author":[{"given":"Xun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6360-4608","authenticated-orcid":false,"given":"Paul Kay Sheung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Chung Yan","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4382-2445","authenticated-orcid":false,"given":"David Shu Cheong","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Miu-Ting","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda Sin-Man","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Chung Lap","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Wai-Kei","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-8331","authenticated-orcid":false,"given":"Chun-Kwok","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"3283_CR1","doi-asserted-by":"publisher","unstructured":"Shivani, S. et al. COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact. Curr Pharmacol Rep. 1\u201316. https:\/\/doi.org\/10.1007\/s40495-020-00229-2 (2020)","DOI":"10.1007\/s40495-020-00229-2"},{"key":"3283_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jama.290.3.374","volume":"290","author":"TW Lew","year":"2003","unstructured":"Lew, T. W. et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 290, 374\u2013380 (2003).","journal-title":"JAMA"},{"key":"3283_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"3283_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","volume":"12","author":"FS Dawood","year":"2012","unstructured":"Dawood, F. S. et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 12, 687\u2013695 (2012).","journal-title":"Lancet Infect. Dis."},{"key":"3283_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"3283_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1086\/650581","volume":"50","author":"KK To","year":"2010","unstructured":"To, K. K. et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin. Infect. Dis. 50, 850\u2013859 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"3283_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/ni.1637","volume":"9","author":"RJ Snelgrove","year":"2008","unstructured":"Snelgrove, R. J. et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat. Immunol. 9, 1074\u20131083 (2008).","journal-title":"Nat. Immunol."},{"key":"3283_CR8","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.4049\/jimmunol.0803743","volume":"182","author":"K Khoufache","year":"2009","unstructured":"Khoufache, K. et al. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J. Immunol. 182, 7795\u20137802 (2009).","journal-title":"J. Immunol."},{"key":"3283_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1164\/rccm.201311-2041LE","volume":"189","author":"S Herold","year":"2014","unstructured":"Herold, S. et al. Inhaled granulocyte\/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome. Am. J. Respiratory Crit. Care Med. 189, 609\u2013611 (2014).","journal-title":"Am. J. Respiratory Crit. Care Med."},{"key":"3283_CR10","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl Acad. Sci. USA 117, 10970\u201310975 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3283_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/BOR.0000000000000361","volume":"29","author":"M Hahn","year":"2017","unstructured":"Hahn, M., Frey, S. & Hueber, A. J. The novel interleukin-1 cytokine family members in inflammatory diseases. Curr. Opin. Rheumatol. 29, 208\u2013213 (2017).","journal-title":"Curr. Opin. Rheumatol."},{"key":"3283_CR12","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1073\/pnas.1121534109","volume":"109","author":"FL van de Veerdonk","year":"2012","unstructured":"van de Veerdonk, F. L. et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc. Natl Acad. Sci. USA 109, 3001\u20133005 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3283_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-020-00937-1","volume":"20","author":"MS Tsang","year":"2020","unstructured":"Tsang, M. S., Sun, X. & Wong, C. K. The role of new IL-1 family members (IL-36 and IL-38) in atopic dermatitis, allergic asthma, and allergic rhinitis. Curr. Allergy Asthma Rep. 20, 40 (2020).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"3283_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/molecules21070933","volume":"21","author":"M Chu","year":"2016","unstructured":"Chu, M. et al. Aberrant expression of novel cytokine IL-38 and regulatory T lymphocytes in childhood asthma. Molecules 21, 933 (2016).","journal-title":"Molecules"},{"key":"3283_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41423-019-0300-7","volume":"17","author":"X Sun","year":"2020","unstructured":"Sun, X. et al. Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma. Cell. Mol. Immunol. 17, 631\u2013646 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"3283_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.imbio.2016.10.012","volume":"222","author":"M Chu","year":"2017","unstructured":"Chu, M. et al. In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)\/lpr mice. Immunobiology 222, 483\u2013493 (2017).","journal-title":"Immunobiology"},{"key":"3283_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/cei.12644","volume":"181","author":"F Ciccia","year":"2015","unstructured":"Ciccia, F. et al. Interleukin-36\u03b1 axis is modulated in patients with primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Immunol. 181, 230\u2013238 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"3283_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cei.12761","volume":"184","author":"MA Boutet","year":"2016","unstructured":"Boutet, M. A. et al. Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease. Clin. Exp. Immunol. 184, 159\u2013173 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"3283_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/mi.2016.107","volume":"10","author":"T Aoyagi","year":"2017","unstructured":"Aoyagi, T. et al. IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia. Mucosal Immunol. 10, 1043\u20131055 (2017).","journal-title":"Mucosal Immunol."},{"key":"3283_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045784","volume":"7","author":"RA Ramadas","year":"2012","unstructured":"Ramadas, R. A., Ewart, S. L., Iwakura, Y., Medoff, B. D. & LeVine, A. M. IL-36\u03b1 exerts pro-inflammatory effects in the lungs of mice. PLoS ONE 7, e45784 (2012).","journal-title":"PLoS ONE"},{"key":"3283_CR21","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1111\/jcmm.14902","volume":"24","author":"Y Ge","year":"2020","unstructured":"Ge, Y., Huang, M., Wu, Y., Dong, N. & Yao, Y. M. Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4(+) CD25(+) regulatory T cells. J. Cell. Mol. Med. 24, 2027\u20132039 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"3283_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/infdis\/jiy289","volume":"218","author":"F Xu","year":"2018","unstructured":"Xu, F. et al. Interleukin 38 protects against lethal sepsis. J. Infect. Dis. 218, 1175\u20131184 (2018).","journal-title":"J. Infect. Dis."},{"key":"3283_CR23","doi-asserted-by":"publisher","first-page":"108315","DOI":"10.1016\/j.clim.2019.108315","volume":"210","author":"YS Chai","year":"2020","unstructured":"Chai, Y. S. et al. IL-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates Th17 differentiation in vivo. Clin. Immunol. 210, 108315 (2020).","journal-title":"Clin. Immunol."},{"key":"3283_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.resinv.2017.06.001","volume":"55","author":"M Tominaga","year":"2017","unstructured":"Tominaga, M. et al. Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis. Respiratory Investig. 55, 293\u2013299 (2017).","journal-title":"Respiratory Investig."},{"key":"3283_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181598","volume":"12","author":"K Takada","year":"2017","unstructured":"Takada, K. et al. Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: possible association with PD-L1 expression. PLoS ONE 12, e0181598 (2017).","journal-title":"PLoS ONE"},{"key":"3283_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1164\/rccm.201901-0214OC","volume":"201","author":"A Watson","year":"2020","unstructured":"Watson, A. et al. Dynamics of IFN-\u03b2 responses during respiratory viral infection. Insights for therapeutic strategies. Am. J. Resp. Crit. care Med. 201, 83\u201394 (2020).","journal-title":"Am. J. Resp. Crit. care Med."},{"key":"3283_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello, G. et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respiratory Cell Mol. Biol. 44, 725\u2013738 (2011).","journal-title":"Am. J. Respiratory Cell Mol. Biol."},{"key":"3283_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., R\u00e9nia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"3283_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1091\/mbc.E17-06-0342","volume":"29","author":"I Papaioannou","year":"2018","unstructured":"Papaioannou, I., Xu, S., Denton, C. P., Abraham, D. J. & Ponticos, M. STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiation. Mol. Biol. Cell 29, 84\u201395 (2018).","journal-title":"Mol. Biol. Cell"},{"key":"3283_CR30","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1073\/pnas.0600771103","volume":"103","author":"Z Si","year":"2006","unstructured":"Si, Z. et al. Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl Acad. Sci. USA 103, 7454\u20137459 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3283_CR31","doi-asserted-by":"publisher","first-page":"49144","DOI":"10.18632\/oncotarget.17100","volume":"8","author":"DD Wu","year":"2017","unstructured":"Wu, D. D. et al. Extracellular signal-regulated kinase 8-mediated NF-\u03baB activation increases sensitivity of human lung cancer cells to arsenic trioxide. Oncotarget 8, 49144\u201349155 (2017).","journal-title":"Oncotarget"},{"key":"3283_CR32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.atherosclerosis.2009.07.035","volume":"208","author":"X Feng","year":"2010","unstructured":"Feng, X. et al. Lipopolysaccharide up-regulates the expression of Fcalpha\/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis 208, 396\u2013405 (2010).","journal-title":"Atherosclerosis"},{"key":"3283_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/path.4423","volume":"235","author":"C Trocme","year":"2015","unstructured":"Trocme, C. et al. Macrophage-specific NOX2 contributes to the development of lung emphysema through modulation of SIRT1\/MMP-9 pathways. J. Pathol. 235, 65\u201378 (2015).","journal-title":"J. Pathol."},{"key":"3283_CR34","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/molecules23081974","volume":"23","author":"HY Kim","year":"2018","unstructured":"Kim, H. Y., Kim, M. S., Kim, S. H., Joen, D. & Lee, K. Protective effects of Nintedanib against polyhexamethylene guanidine phosphate-induced lung fibrosis in mice. Molecules 23, 1974 (2018).","journal-title":"Molecules"},{"key":"3283_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/infdis\/jix636","volume":"218","author":"R Zheng","year":"2018","unstructured":"Zheng, R. et al. Notch4 negatively regulates the inflammatory response to Mycobacterium tuberculosis infection by inhibiting TAK1 activation. J. Infect. Dis. 218, 312\u2013323 (2018).","journal-title":"J. Infect. Dis."},{"key":"3283_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3109\/01902148.2011.581738","volume":"37","author":"J Knaapi","year":"2011","unstructured":"Knaapi, J., Lukkarinen, H., Kiviranta, R., Vuorio, E. & K\u00e4\u00e4p\u00e4, P. Cathepsin K deficiency aggravates lung injury in hyperoxia-exposed newborn mice. Exp. Lung Res. 37, 408\u2013418 (2011).","journal-title":"Exp. Lung Res."},{"key":"3283_CR37","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.1128\/JVI.01068-14","volume":"88","author":"F Aeffner","year":"2014","unstructured":"Aeffner, F., Woods, P. S. & Davis, I. C. Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A\/WSN\/33 (H1N1) virus. J. Virol. 88, 10214\u201310227 (2014).","journal-title":"J. Virol."},{"key":"3283_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1165\/rcmb.2013-0471OC","volume":"51","author":"K Ganguly","year":"2014","unstructured":"Ganguly, K. et al. Secreted phosphoprotein 1 is a determinant of lung function development in mice. Am. J. Resp. Cell Mol. Biol. 51, 637\u2013651 (2014).","journal-title":"Am. J. Resp. Cell Mol. Biol."},{"key":"3283_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","volume":"45","author":"M De Simone","year":"2016","unstructured":"De Simone, M. et al. Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells. Immunity 45, 1135\u20131147 (2016).","journal-title":"Immunity"},{"key":"3283_CR40","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00018-015-1879-1","volume":"72","author":"N Li","year":"2015","unstructured":"Li, N. et al. Influenza infection induces host DNA damage and dynamic DNA damage responses during tissue regeneration. Cell. Mol. Life Sci. 72, 2973\u20132988 (2015).","journal-title":"Cell. Mol. Life Sci."},{"key":"3283_CR41","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1183\/09031936.00050612","volume":"41","author":"CS Lee","year":"2013","unstructured":"Lee, C. S. et al. Simvastatin suppresses RANTES-mediated neutrophilia in polyinosinic-polycytidylic acid-induced pneumonia. Eur. Respiratory J. 41, 1147\u20131156 (2013).","journal-title":"Eur. Respiratory J."},{"key":"3283_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1074\/jbc.M116.753186","volume":"292","author":"I Kang","year":"2017","unstructured":"Kang, I. et al. Versican deficiency significantly reduces lung inflammatory response induced by polyinosine-polycytidylic acid stimulation. J. Biol. Chem. 292, 51\u201363 (2017).","journal-title":"J. Biol. Chem."},{"key":"3283_CR43","doi-asserted-by":"publisher","first-page":"17021","DOI":"10.1038\/celldisc.2017.21","volume":"3","author":"Q Liu","year":"2017","unstructured":"Liu, Q. et al. miRNA-200c-3p is crucial in acute respiratory distress syndrome. Cell Discov. 3, 17021 (2017).","journal-title":"Cell Discov."},{"key":"3283_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007001","volume":"14","author":"AP Gounder","year":"2018","unstructured":"Gounder, A. P. et al. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 14, e1007001 (2018).","journal-title":"PLoS Pathog."},{"key":"3283_CR45","doi-asserted-by":"publisher","first-page":"e02202","DOI":"10.1128\/JVI.02202-17","volume":"92","author":"P Hillyer","year":"2018","unstructured":"Hillyer, P. et al. Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control. J. Virol. 92, e02202\u2013e02217 (2018).","journal-title":"J. Virol."},{"key":"3283_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/infdis\/jis721","volume":"207","author":"C Mella","year":"2013","unstructured":"Mella, C. et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J. Infect. Dis. 207, 564\u2013573 (2013).","journal-title":"J. Infect. Dis."},{"key":"3283_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cytogfr.2018.01.001","volume":"39","author":"T Garraud","year":"2018","unstructured":"Garraud, T., Harel, M., Boutet, M. A., Le Goff, B. & Blanchard, F. The enigmatic role of IL-38 in inflammatory diseases. Cytokine Growth Factor Rev. 39, 26\u201335 (2018).","journal-title":"Cytokine Growth Factor Rev."},{"key":"3283_CR48","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1172\/JCI61303","volume":"122","author":"A Caudrillier","year":"2012","unstructured":"Caudrillier, A. et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Investig. 122, 2661\u20132671 (2012).","journal-title":"J. Clin. Investig."},{"key":"3283_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003188","volume":"9","author":"K H\u00f6gner","year":"2013","unstructured":"H\u00f6gner, K. et al. Macrophage-expressed IFN-\u03b2 contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 9, e1003188 (2013).","journal-title":"PLoS Pathog."},{"key":"3283_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0002-9440(10)63950-8","volume":"158","author":"JA Wiley","year":"2001","unstructured":"Wiley, J. A., Cerwenka, A., Harkema, J. R., Dutton, R. W. & Harmsen, A. G. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am. J. Pathol. 158, 119\u2013130 (2001).","journal-title":"Am. J. Pathol."},{"key":"3283_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1084\/jem.188.2.223","volume":"188","author":"D Moskophidis","year":"1998","unstructured":"Moskophidis, D. & Kioussis, D. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 188, 223\u2013232 (1998).","journal-title":"J. Exp. Med."},{"key":"3283_CR52","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","volume":"162","author":"N Arpaia","year":"2015","unstructured":"Arpaia, N. et al. A distinct function of regulatory T cells in tissue protection. Cell 162, 1078\u20131089 (2015).","journal-title":"Cell"},{"key":"3283_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/cc9324","volume":"14","author":"N Hagau","year":"2010","unstructured":"Hagau, N. et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit. care 14, R203 (2010).","journal-title":"Crit. care"},{"key":"3283_CR54","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.4049\/jimmunol.0900995","volume":"183","author":"CR Crowe","year":"2009","unstructured":"Crowe, C. R. et al. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 183, 5301\u20135310 (2009).","journal-title":"J. Immunol."},{"key":"3283_CR55","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.0705289104","volume":"104","author":"R Salomon","year":"2007","unstructured":"Salomon, R., Hoffmann, E. & Webster, R. G. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl Acad. Sci. USA 104, 12479\u201312481 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3283_CR56","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4049\/jimmunol.160.2.1007","volume":"160","author":"MV Parsey","year":"1998","unstructured":"Parsey, M. V., Tuder, R. M. & Abraham, E. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J. Immunol. 160, 1007\u20131013 (1998).","journal-title":"J. Immunol."},{"key":"3283_CR57","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2249.1993.tb05924.x","volume":"91","author":"S Gatti","year":"1993","unstructured":"Gatti, S., Faggioni, R., Echtenacher, B. & Ghezzi, P. Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin. Exp. Immunol. 91, 456\u2013461 (1993).","journal-title":"Clin. Exp. Immunol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03283-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:24:01Z","timestamp":1697520241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03283-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03283-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"6 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"53"}}